Works matching DE "PHARMACEUTICAL industry %26 ethics"
Results: 80
Pharmaceutical representatives' beliefs and practices about their professional practice: a study in Sudan.
- Published in:
- Eastern Mediterranean Health Journal, 2012, v. 18, n. 8, p. 821, doi. 10.26719/2012.18.8.821
- By:
- Publication type:
- Article
Publicidad y promoción de medicamentos: regulaciones y grado de acatamiento en cinco países de América Latina.
- Published in:
- Pan American Journal of Public Health / Revista Panamericana de Salud Pública, 2011, v. 29, n. 2, p. 76, doi. 10.1590/S1020-49892011000200002
- By:
- Publication type:
- Article
Pricing for Orphan Drugs.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Direct-to-Consumer Advertising of Pharmaceuticals as a Matter of Corporate Social Responsibility?
- Published in:
- Journal of Business Ethics, 2010, v. 94, n. 2, p. 211, doi. 10.1007/s10551-009-0257-z
- By:
- Publication type:
- Article
Industry and Chain Responsibilities and Integrative Social Contracts Theory.
- Published in:
- Journal of Business Ethics, 2009, v. 88, p. 751, doi. 10.1007/s10551-009-0327-2
- By:
- Publication type:
- Article
Let Them Eat (Genetically Re-engineered) Cake and the Little Purple Pill: A Rejoinder to Miles, Munilla and Covin.
- Published in:
- Journal of Business Ethics, 2005, v. 57, n. 2, p. 111, doi. 10.1007/s10551-004-1525-6
- By:
- Publication type:
- Article
Ethical Considerations in the Use of Direct-To-Consumer Advertising and Pharmaceutical Promotions: The Impact on Pharmaceutical Sales and Physicians.
- Published in:
- Journal of Business Ethics, 2003, v. 48, n. 3, p. 279, doi. 10.1023/B:BUSI.0000005783.58142.6e
- By:
- Publication type:
- Article
Patently Innovative: How Pharmaceutical Firms Use Emerging Patent Law to Extend Monopolies on Blockbuster Drugs and Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries.
- Published in:
- Journal of Legal Medicine, 2013, v. 34, n. 1, p. 149, doi. 10.1080/01947648.2013.768509
- By:
- Publication type:
- Article
Silence Is Not the Best Medicine: Requiring Disclosure of Clinical Trial Data for Abandoned Drugs.
- Published in:
- Journal of Legal Medicine, 2012, v. 33, n. 4, p. 571, doi. 10.1080/01947648.2012.739072
- By:
- Publication type:
- Article
An Ethical Dilemma.
- Published in:
- Journal of Legal Medicine, 2012, v. 33, n. 1, p. 115, doi. 10.1080/01947648.2012.657939
- By:
- Publication type:
- Article
Interactions between Doctors and Pharmaceutical Sales Representatives in a Former Communist Country.
- Published in:
- Cambridge Quarterly of Healthcare Ethics, 2014, v. 23, n. 3, p. 349, doi. 10.1017/S0963180113000960
- By:
- Publication type:
- Article
Does the Pharmaceutical Sector Have a Coresponsibility for the Human Right to Health?
- Published in:
- Cambridge Quarterly of Healthcare Ethics, 2011, v. 20, n. 2, p. 298, doi. 10.1017/S0963180110000952
- By:
- Publication type:
- Article
Bad Pharma.
- Published in:
- 2013
- By:
- Publication type:
- Book Review
Lecture Circuit.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Edits to ethics code rankle.
- Published in:
- Nature, 2014, v. 515, n. 7526, p. 174, doi. 10.1038/515174a
- By:
- Publication type:
- Article
Drug companies should report clinical trial results, even when they won't lead to a product.
- Published in:
- Formulary, 2011, v. 46, n. 10, p. 404
- Publication type:
- Article
PRICELESS GOODS: HOW SHOULD LIFE-SAVING DRUGS BE PRICED?
- Published in:
- Business Ethics Quarterly, 2002, v. 12, n. 4, p. 451, doi. 10.2307/3857995
- By:
- Publication type:
- Article
CMS issues final rule on Physician Payment Sunshine Act.
- Published in:
- Ocular Surgery News, 2013, v. 31, n. 5, p. 4
- Publication type:
- Article
Financial Toxicity of Cancer Drugs: Possible Remedies from an Ethical Perspective.
- Published in:
- Breast Care, 2017, v. 12, n. 2, p. 81, doi. 10.1159/000471506
- By:
- Publication type:
- Article
Unpredictable Drug Shortages: An Ethical Framework for Short-Term Rationing in Hospitals.
- Published in:
- American Journal of Bioethics, 2012, v. 12, n. 1, p. 1, doi. 10.1080/15265161.2011.634483
- By:
- Publication type:
- Article
PhRMA's Code on Interactions With Healthcare Professionals.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
All Gifts Large and Small: Toward an Understanding of the Ethics of Pharmaceutical Industry Gift-Giving.
- Published in:
- American Journal of Bioethics, 2010, v. 10, n. 10, p. 11, doi. 10.1080/15265161.2010.519226
- By:
- Publication type:
- Article
FDA Approval of Tisagenlecleucel: Promise and Complexities of a $475 000 Cancer Drug.
- Published in:
- 2017
- By:
- Publication type:
- journal article
EXPLOITATIONS AND THEIR COMPLICATIONS: THE NECESSITY OF IDENTIFYING THE MULTIPLE FORMS OF EXPLOITATION IN PHARMACEUTICAL TRIALS.
- Published in:
- Bioethics, 2012, v. 26, n. 5, p. 251, doi. 10.1111/j.1467-8519.2010.01847.x
- By:
- Publication type:
- Article
FINANCIAL CONFLICTS OF INTEREST AND THE ETHICAL OBLIGATIONS OF MEDICAL SCHOOL FACULTY AND THE PROFESSION.
- Published in:
- 2010
- By:
- Publication type:
- Essay
The Drug Price Controversy Nobody Notices.
- Published in:
- Milbank Quarterly, 2016, v. 94, n. 2, p. 260, doi. 10.1111/1468-0009.12193
- By:
- Publication type:
- Article
Withholding Information on Unapproved Drug Marketing Applications: The Public Has a Right to Know.
- Published in:
- Journal of Law, Medicine & Ethics, 2017, v. 45, p. 46, doi. 10.1177/1073110517750621
- By:
- Publication type:
- Article
Curing the Disobedient Patient: Medication Adherence Programs as Pharmaceutical Marketing Tools.
- Published in:
- Journal of Law, Medicine & Ethics, 2014, v. 42, n. 4, p. 492, doi. 10.1111/jlme.12170
- By:
- Publication type:
- Article
From Community to Commodity: The Ethics of Pharma-Funded Social Networking Sites for Physicians.
- Published in:
- Journal of Law, Medicine & Ethics, 2013, v. 41, n. 3, p. 673, doi. 10.1111/jlme.12077
- By:
- Publication type:
- Article
"Institutional Corruption" Defined.
- Published in:
- Journal of Law, Medicine & Ethics, 2013, v. 41, n. 3, p. 553, doi. 10.1111/jlme.12063
- By:
- Publication type:
- Article
Effect of Financial Relationships on the Behaviors of Health Care Professionals: A Review of the Evidence.
- Published in:
- Journal of Law, Medicine & Ethics, 2012, v. 40, n. 3, p. 452, doi. 10.1111/j.1748-720X.2012.00678.x
- By:
- Publication type:
- Article
Conflicts of Interest, Institutional Corruption, and Pharma: An Agenda for Reform.
- Published in:
- Journal of Law, Medicine & Ethics, 2012, v. 40, n. 3, p. 511, doi. 10.1111/j.1748-720X.2012.00683.x
- By:
- Publication type:
- Article
Pharmaceutical Companies and Global Lack of Access to Medicines: Strengthening Accountability under the Right to Health.
- Published in:
- Journal of Law, Medicine & Ethics, 2012, v. 40, n. 2, p. 234, doi. 10.1111/j.1748-720X.2012.00661.x
- By:
- Publication type:
- Article
Too Fast or Not Too Fast: The FDA's Approval of Merck's HPV Vaccine Gardasil.
- Published in:
- Journal of Law, Medicine & Ethics, 2012, v. 40, n. 3, p. 673, doi. 10.1111/j.1748-720X.2012.00698.x
- By:
- Publication type:
- Article
Pharmaceutical Companies vs. the State: Who Is Responsible for Post-Trial Provision of Drugs in Brazil?
- Published in:
- Journal of Law, Medicine & Ethics, 2012, v. 40, n. 2, p. 188, doi. 10.1111/j.1748-720X.2012.00657.x
- By:
- Publication type:
- Article
Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines.
- Published in:
- Journal of Law, Medicine & Ethics, 2012, v. 40, n. 2, p. 220, doi. 10.1111/j.1748-720X.2012.00660.x
- By:
- Publication type:
- Article
INTRODUCTION: Pharmaceutical Firms and the Right to Health.
- Published in:
- Journal of Law, Medicine & Ethics, 2012, v. 40, n. 2, p. 183, doi. 10.1111/j.1748-720X.2012.00656.x
- By:
- Publication type:
- Article
Pharmaceutical Speakers' Bureaus, Academic Freedom, and the Management of Promotional Speaking at Academic Medical Centers.
- Published in:
- Journal of Law, Medicine & Ethics, 2012, v. 40, n. 2, p. 311, doi. 10.1111/j.1748-720X.2012.00666.x
- By:
- Publication type:
- Article
Damned If You Do, Damned If You Don't? The Lundbeck Case of Pentobarbital, the Guiding Principles on Business and Human Rights, and Competing Human Rights Responsibilities.
- Published in:
- Journal of Law, Medicine & Ethics, 2012, v. 40, n. 2, p. 206, doi. 10.1111/j.1748-720X.2012.00659.x
- By:
- Publication type:
- Article
Attitudes of physicians and public to pharmaceutical industry ‘gifts’.
- Published in:
- Internal Medicine Journal, 2010, v. 40, n. 5, p. 335, doi. 10.1111/j.1445-5994.2010.02233.x
- By:
- Publication type:
- Article
Big Pharma and the Problem of Disease Inflation.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Speakers call for upholding professional ethics by Medical Profession and Pharma Industry.
- Published in:
- 2016
- Publication type:
- Proceeding
From Here to Biosecurity: Advice for an Incoming Administration.
- Published in:
- BioScience, 2008, v. 58, n. 11, p. 1006, doi. 10.1641/B581102
- By:
- Publication type:
- Article
SEX, LIES & PHARMACEUTICALS: HOW DRUG COMPANIES PLAN TO PROFIT FROM FEMALE SEXUAL DYSFUNCTION.
- Published in:
- 2013
- By:
- Publication type:
- Book Review
Statement of Concern.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Are Drug Companies Living Up to Their Human Rights Responsibilities? The Perspective of the Former United Nations Special Rapporteur (2002-2008).
- Published in:
- PLoS Medicine, 2010, v. 7, n. 9, p. 1, doi. 10.1371/journal.pmed.1000330
- By:
- Publication type:
- Article
Are Drug Companies Living Up to Their Human Rights Responsibilities? Moving Toward Assessment.
- Published in:
- PLoS Medicine, 2010, v. 7, n. 9, p. 1, doi. 10.1371/journal.pmed.1000310
- By:
- Publication type:
- Article
The Disposable Author: How Pharmaceutical Marketing Is Embraced within Medicine's Scholarly Literature.
- Published in:
- Hastings Center Report, 2016, v. 46, n. 4, p. 31, doi. 10.1002/hast.576
- By:
- Publication type:
- Article
THE TRIANGLE PHYSICIAN-PHARMACIST-PHARMACEUTICAL REPRESENTATIVE IN THE PRESCRIBING-PROMOTING-DISPENSING DRUG PROCESS - ETHICAL ISSUES.
- Published in:
- Studia Universitatis Babes-Bolyai, Bioethica (2011), 2016, v. 61, n. 1/2, p. 11
- By:
- Publication type:
- Article
Entangling Experts.
- Published in:
- Journal of Pharmacy Practice & Research, 2011, v. 41, n. 3, p. 179, doi. 10.1002/j.2055-2335.2011.tb00855.x
- By:
- Publication type:
- Article